Moleculent (Series A)

Funding Details
Awarder
Inbox
Date Award
June 11, 2024
Vertical
Biotech
Funding URL
View Funding Page

Company Info
Founders
Olle Ericsson
Company Description
Moleculent, headquartered in Stockholm, is focused on advancing its functional biology platform, which enables the mapping of cell-cell communication directly in clinical tissue. By detecting and profiling cell-to-cell interactions within their tissue environment, Moleculent aims to enhance the understanding of cell communication networks, disease pathways, and drug responses.
Market
Healthcare
Location
Stockholm, Sweden
Coinvestors
Arch Venture Partners, Eir Ventures

Links
Back to Home Back to Biotech Deals View Funding Announcement